Mother and child (MDMG) Sɔɔtɔ Fɔrɛkɛst
AI forecast: MDMG
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
